by Chiranjir Narine, MD; Jennifer Weller, PhD; and Kathleen Mathieson, PhD, CIP Dr. Narine is the Medical Director of Valleywise Behavioral Health/District Medical Group in Phoenix, Arizona. Dr. Weller is
by Zainab Saherwala, DO; Sabina Bashir, BA; and Danielle Gainer, MD Drs. Saherwala and Gainer and Student Doctor Bashir are with Wright State University in Fairborn, Ohio. FUNDING: No funding
by Sittichai Khamsai, MD; Kathleen Howe, MSc; Pewpan M. Intapan, MD; Wanchai Maleewong, PhD; Verajit Chotmongkol, MD; and Kittisak Sawanyawisuth, MD, PhD Drs. Khamsai, Chotmongkol, and Sawanyawisuth are with the
by Ann L. McNary, JD Ms. McNary is a Senior Risk Manager at PRMS, Inc. FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is
Dear Editor: COVID-19 is having a tremendous impact on the healthcare and economic systems worldwide, as well as on human behavior, negatively affecting both personal and social relationships. COVID-19 is
Dear Editor: Parkinson’s disease (PD) affects over 600,000 patients in the United States; these numbers might double by 2040, as the population of older people increases.1 Diagnostic clues include the
by Evangelia Bountouvi, MD, PhD; Melpomeni Giorgi, MD; Anna Papadopoulou, PhD; Kaj Blennow, PhD; Ingemar Björkhem, PhD; Maria Tsirouda, PhD; Spyridon Kanellakis, Msc, PhD; Andreas Fryganas, MD; Maria Spanou, MD;
by Philip B Cawkwell, MD; Ivan Daniel Mayor, BA; and Richard J. Shaw,MD Drs. Cawkwell and Shaw and Mr. Mayor are with the Department of Psychiatry and Behavioral Sciences, Division
by Atmaram Yarlagadda, MD; Samuel L. Preston, DO; Rachel P. Jeyadhas, MD; Adam Edward Lang, PharmD; Rasha Hammamieh, PhD; And Anita H. Clayton, MD Dr. Yarlagadda is the Installation Director
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne C. Moore, PhD; Colin A. Depp, PhD; Emma M. Parrish, BS; and Amy E. Pinkham, PhD Dr. Harvey is with
by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with
[protected]by Aksha M. Memon, MD, MPH Dr. Memon is an Assistant Professor with the Department of Foundational Medical Studies at Oakland University William Beaumont School of Medicine in Rochester Hills,
by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Sunlight Brain Research Center in Hofu, Yamaguchi, Japan. FUNDING: No funding was provided for this study. DISCLOSURES: The author has
by Ann L. McNary, JD Ms. McNary is a Senior Risk Manager at PRMS, Inc. FUNDING: No funding was provided for the preparation of this article. DISCLOSURES: The author is
Dear Editor: We read the excellent article by Diaz-Abad et al1 about a 54-year-old male patient with double seronegative myasthenia gravis. In the article, Diaz et al1 explained the patient
by Yousra BENMAKHLOUF, PhD; Zeineb ZIAN, PhD; Kaoutar BEN MAKHLOUF; Naima GHAILANI NOUROUTI, PR; Amina BARAKAT, PR; and Mohcine BENNANI MECHITA PR Drs. Benmakhlouf, Zian, Ghailani Nourouti, Barakat, and Bennani
by Rocco Salvatore Calabrò, MD, PhD; Claudia Müller-Eising, Dr. jur.; Maria Letizia Diliberti; Alfredo Manuli, MSc; Francesca Parrinello, MD; Giuseppe Rao, MD; Vincenzo Barone, Dr. jur.; and Tamara Civello Drs.
Integration of Advanced Health Technology Within the Healthcare System to Fight the Global Pandemic: Current Challenges and Future Opportunities
by Tarneem Darwish, MD; Samuel Korouri, BA; Mia Pasini, RN, MSN; Maria Veronica Cortez, RN; and Waguih William IsHak, MD, FAPA Drs. Darwish and IsHak and Mr. Korouri, Ms. Pasini,
Read More